Evidence map›Paper›PMID 35440725›Full record

ArticleNature medicine2022

Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.

Bob T Li, Bobby Daly, Mary Gospodarowicz, Monica M Bertagnolli, Otis W Brawley, Bruce A Chabner, Lola Fashoyin-Aje, R Angelo de Claro, Elizabeth Franklin, Jennifer Mills and 24 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Focused ultrasound for brain metastases.Neuro-oncology advances · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Nutritional guidance needs and influence factors for gastric cancer survivors in primary healthcare setting: a cross-sectional survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Bob T Li *Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA. lib1@mskcc.org.ORCID http://orcid.org/0000-0001-6661-8733
Bobby Daly *Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Mary GospodarowiczPrincess Margaret Cancer Center, , University of Toronto, Toronto, Ontario, Canada.
Monica M BertagnolliDana-Farber Brigham Cancer Center, Harvard Medical School, Boston, MA, USA.
Otis W BrawleyJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Bruce A ChabnerMassachusetts General Hospital Cancer Center, Boston, MA, USA.
Lola Fashoyin-AjeOncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA.
R Angelo de ClaroOncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA.
Elizabeth FranklinCancer Support Community, Washington, DC, USA.
Jennifer MillsFoundation Medicine, Inc., Cambridge, MA, USA.
Jeff LegosNovartis, Basel, Switzerland.
Karen KaucicPPD, Inc., Wilmington, NC, USA.
Mark LiResolution Bioscience, Agilent Technologies, Kirkland, WA, USA.
Lydia TheMcKinsey Cancer Center, McKinsey & Company.
Tina HouMcKinsey Cancer Center, McKinsey & Company.
Ting-Hui WuMcKinsey Cancer Center, McKinsey & Company.
Bjorn AlbrechtMcKinsey Cancer Center, McKinsey & Company.
Yi ShaoMcKinsey Cancer Center, McKinsey & Company.
Justin FinneganBloomberg New Economy, Bloomberg L.P., New York, NY, USA.
Jing QianAsia Society Policy Institute, Asia Society, New York, NY, USA.
Javad ShahidiDaiichi Sankyo, Tokyo, Japan.
Eduard GasalInnovent Biologics, Suzhou, China.
Craig TendlerJanssen, Johnson and Johnson, New Brunswick, NJ, USA.
Geoffrey KimBeiGene USA, BeiGene, Beijing, China.
James YanZai Lab, Shanghai, China.
Phuong Khanh MorrowAmgen, Inc, Thousand Oaks, CA, USA.
Charles S FuchsGenentech, South San Francisco, CA, USA.
Lianshan ZhangJiangsu Hengrui Pharmaceuticals, Shanghai, China.
Robert LaCazeBayer AG, Leverkusen, Germany.
Stefan OelrichBayer AG, Leverkusen, Germany.
Martin J MurphySociety for Translational Oncology, Durham, NC, USA.
Richard PazdurOncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA.
Kevin RuddAsia Society Policy Institute, Asia Society, New York, NY, USA.
Yi-Long WuGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Chinese Thoracic Oncology Group, Guangzhou, China.ORCID http://orcid.org/0000-0002-3611-0258

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsClinical Trials as TopicHumansPatient-Centered Care

Identifiers

PMID35440725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.